Clinical Trials
5
Active:0
Completed:3
Trial Phases
1 Phases
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (100.0%)Evaluation of Safety and Efficacy of DM-28 for Treatment of Moderate to Severe Ocular Dryness
Not Applicable
Completed
- Conditions
- Dry Eye
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Horus Pharma
- Target Recruit Count
- 44
- Registration Number
- NCT06607237
- Locations
- 🇵🇱
Eurofins Dermscan Poland, Gdańsk, Poland
🇵🇱Tu sie Leczy, Gdańsk, Poland
Evaluation of the Efficacy and Safety of DM934 Versus Théalose on Eye Dryness
Not Applicable
Completed
- Conditions
- Dry Eye
- First Posted Date
- 2024-02-07
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Horus Pharma
- Target Recruit Count
- 85
- Registration Number
- NCT06245421
- Locations
- 🇫🇷
Eurofins Dermscan, Aix-en-Provence, France
🇫🇷Eurofins EVIC, Bordeaux, France
🇵🇱Eurofins Dermscan Poland, Gdańsk, Poland
Evaluation of Neovis® Total Multi Versus Systane® Balance on Ocular Dryness Associated With Meibomian Gland Dysfunction
Not Applicable
- Conditions
- Dry EyeMeibomian Gland Dysfunction
- First Posted Date
- 2022-01-13
- Last Posted Date
- 2022-01-13
- Lead Sponsor
- Horus Pharma
- Target Recruit Count
- 120
- Registration Number
- NCT05191771
Evaluation of Efficacy and Safety of Vismed Gel Multi 0.3% Versus Vismed Multi 0.18% on Treatment of Ocular Dryness
Not Applicable
- Conditions
- Dry Eye
- First Posted Date
- 2018-08-24
- Last Posted Date
- 2018-08-24
- Lead Sponsor
- Horus Pharma
- Target Recruit Count
- 80
- Registration Number
- NCT03645850
Evaluation of the Efficacy and Safety of DM05 Versus Optive™ on the Treatment of Moderate to Severe Ocular Dryness
Not Applicable
Completed
- Conditions
- Dry Eye
- First Posted Date
- 2018-05-07
- Last Posted Date
- 2018-05-07
- Lead Sponsor
- Horus Pharma
- Target Recruit Count
- 80
- Registration Number
- NCT03517748
News
No news found